U.S. Poultry Medicine Market Size, Share & Trends Analysis Report 2025-2033 Shift Towards Antibiotic Alternatives Drives Growth, New Vaccines And Diagnostics Revolutionize Poultry Health Management

(MENAFN- GlobeNewsWire - Nasdaq) The U.S. poultry medicine market, valued at USD 1.83 billion in 2024, is expected to soar to USD 3.11 billion by 2033, at a CAGR of 6.20%. High poultry consumption, reduced antibiotic use, and technological advances drive this growth. Key trends include antibiotic alternatives and efficient farming practices.

Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "U.S. Poultry Medicine Market Size, Share & Trends Analysis Report By Species (Chicken, Turkey, Ducks), By Product (Biologics, Pharmaceuticals), By Disease Type, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2033" report has been added to ResearchAndMarkets.com's offering.
The U.S. poultry medicine market size was estimated at USD 1.83 billion in 2024 and is projected to reach USD 3.11 billion by 2033, growing at a CAGR of 6.20% from 2025 to 2033

The market is continuously growing, driven by high poultry consumption and market value, a shift towards antibiotic alternatives, and technological advancements in poultry healthcare. According to the USDA Economic Research Service, U.S. poultry products dominate both domestic and global meat markets, due to efficient production systems, advanced genetics, ample feed supply, and strong consumer demand. Between 2013 and 2022, broilers accounted for 67% of poultry sales, followed by eggs at 22% and turkeys at 11%, primarily for consumption.

This surge in demand for poultry products directly translates into the need for efficient and sustainable poultry farming practices, necessitating comprehensive healthcare solutions to maintain the health and productivity of poultry flocks. The per capita consumption of poultry, from 2020 to 2024, is illustrated below in the chart:
Growing concerns over antimicrobial resistance have prompted the U.S. poultry industry to reduce antibiotic use. Regulations like the Preservation of Antibiotics for Medical Treatment Act (PAMTA) and the Preventing Antibiotic Resistance Act (PARA) have restricted the use of medically important antibiotics in poultry and livestock.

For decades, antibiotics have been widely used in livestock and poultry, as high-dose treatments for specific infections and as low-dose growth promoters in animal feed. In 2013, around 131,000 tons of antibiotics were used in food animals, a number projected to increase to nearly 200,000 tons by 2030 due to rising global demand. This shift has led to increased demand for alternative health management strategies, such as vaccines, probiotics, and herbal supplements, to ensure poultry health and productivity.
Advancements in veterinary and animal nutrition technologies have significantly impacted the U.S. poultry pharmaceuticals market. The development of new vaccines, diagnostic tools, feed supplements, and other specialized healthcare products has enabled poultry producers to address a wider range of health challenges, improve flock performance, and enhance food safety. These innovations contribute to more efficient and sustainable poultry farming practices.

Why should you buy this report?

• Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
• Competitive Landscape: Explore the market presence of key players worldwide.
• Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
• Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Key Attributes:

Report Attribute	Details
No. of Pages	150
Forecast Period	2024 - 2033
Estimated Market Value (USD) in 2024	$1.83 Billion
Forecasted Market Value (USD) by 2033	$3.11 Billion
Compound Annual Growth Rate	6.2%
Regions Covered	United States

Market Dynamics

• Market Driver Analysis
• High poultry consumption and market value
• Shift towards antibiotic alternatives
• Technological advancements in poultry healthcare

Market Restraint Analysis

• Stringent regulatory compliance and approval processes

U.S. Poultry Medicine Market Analysis Tools

• Industry Analysis - Porter's
• PESTEL Analysis

Regulatory Framework

Pricing Analysis

Product Pipeline Analysis

Estimated Poultry Population in U.S., 2024

Competitive Landscape

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Vaxxinova International BV
• Merck & Co., Inc.
• Elanco
• Ceva Sante Animale
• Phibro Animal Health Corporation
• Virbac
• Hipra
• Vetanco
• Kemin Industries, Inc.
  
  • Market Participant Categorization
  • Company Market Position Analysis/ Heat Map Analysis
  • Participant's Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives

U.S. Poultry Medicine Market Report Segmentation
Species Outlook (Revenue, USD Million, 2021 - 2033)

• Chicken
• Broiler
• Layer
• Turkey
• Ducks
• Others

Product Outlook (Revenue, USD Million, 2021 - 2033)

• Biologics
• Vaccines
• Modified/ Attenuated Live
• Inactivated (Killed)
• Other Vaccines
• Other Biologics
• Pharmaceuticals
• Parasiticides
• Anti-infectives
• Anti-inflammatory
• Analgesics
• Others
• Medicated Feed Additives

Disease Type Outlook (Revenue, USD Million, 2021 - 2033)

• Newcastle Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Coccidiosis
• Salmonella
• Marek's Disease
• Others

Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)

• Oral
• Injectable
• Topical
• Others

Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Veterinary Hospitals & Clinics
• E-commerce
• Offline Retail Stores
• Others

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• U.S. Poultry Medicine Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN28072025004107003653ID1109850620